Abstract
This mini-review paper does not consider classical work concerning the formation of inclusion complexes between pharmaceuticals and cyclodextrins. Instead, it highlights recent reports concerning the association of these host:guest systems with other carrier systems such as liposomes and nanoparticles showing the state of art of this subject with examples of developed systems and the advantages of these strategy in order to be potential systems as drug carriers.
Keywords: Cyclodextrin, liposome, nanoparticle, drug delivery.
Current Topics in Medicinal Chemistry
Title:Cyclodextrin Inclusion Complexes Loaded in Particles as Drug Carrier Systems
Volume: 14 Issue: 4
Author(s): Leonardo Fernandes Fraceto, Renato Grillo and Eduardo Sobarzo-Sanchez
Affiliation:
Keywords: Cyclodextrin, liposome, nanoparticle, drug delivery.
Abstract: This mini-review paper does not consider classical work concerning the formation of inclusion complexes between pharmaceuticals and cyclodextrins. Instead, it highlights recent reports concerning the association of these host:guest systems with other carrier systems such as liposomes and nanoparticles showing the state of art of this subject with examples of developed systems and the advantages of these strategy in order to be potential systems as drug carriers.
Export Options
About this article
Cite this article as:
Fraceto Fernandes Leonardo, Grillo Renato and Sobarzo-Sanchez Eduardo, Cyclodextrin Inclusion Complexes Loaded in Particles as Drug Carrier Systems, Current Topics in Medicinal Chemistry 2014; 14(4) . https://dx.doi.org/10.2174/1568026613666131219124847
DOI https://dx.doi.org/10.2174/1568026613666131219124847 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
CXCR4 Inhibitors: Tumor Vasculature and Therapeutic Challenges
Recent Patents on Anti-Cancer Drug Discovery Trans-Platinum Complexes with Promising Antitumor Properties
Medicinal Chemistry Reviews - Online (Discontinued) The Role of Insulin Receptor Isoforms and Hybrid Insulin/IGF-I Receptors in Human Cancer
Current Pharmaceutical Design MICA Gene and Relevance to Immune Responses in Organ Transplants and Inflammatory, Tumoral and Autoimmune Diseases
Current Immunology Reviews (Discontinued) Application of Molecular Imaging Technologies in Antitumor Drug Development and Therapy
Current Pharmaceutical Design PET Imaging to Monitor Cancer Therapy
Current Pharmaceutical Biotechnology Transcriptionally Targeted Adenovirus Vectors
Current Gene Therapy A Targeted Therapy for Protein and Lipid Kinases in Chronic Lymphocytic Leukemia
Current Medicinal Chemistry Plumbagin: A Potential Anti-cancer Compound
Mini-Reviews in Medicinal Chemistry When BMP Signalling Goes Wrong: The Intracellular and Molecular Mechanisms of BMP Signalling in Cancer
Current Signal Transduction Therapy Combination Therapy of Cisplatin and other Agents for Osteosarcoma: A Review
Current Cancer Therapy Reviews Regulation of Hypoxia-inducible Factor-1α and Vascular Endothelial Growth Factor Signaling by Plant Flavonoids
Mini-Reviews in Medicinal Chemistry Recent Progress in Oleanolic Acid: Structural Modification and Biological Activity
Current Topics in Medicinal Chemistry PRL-3, An Emerging Marker of Carcinogenesis, Is Strongly Associated with Poor Prognosis
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Potential and Outlook of Alternative Medicine for Osteoporosis
Current Drug Targets Current Status and Future Perspective for Research on Medicinal Plants with Anticancerous Activity and Minimum Cytotoxic Value
Current Drug Targets Thymidine Kinase-Mediated Shut Down of Bone Morphogenetic Protein-4 Expression Allows Regulated Bone Production
Current Gene Therapy Sirtuin Inhibitors: An Overview from Medicinal Chemistry Perspective
Anti-Cancer Agents in Medicinal Chemistry Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective
Current Pharmaceutical Design Hypoxia-Inducible Factor-1 (HIF-1): A Potential Target for Intervention in Ocular Neovascular Diseases
Current Drug Targets